Document Detail


Influence of glucocorticoid and betamimetic therapy on milk secretory IgA concentration produced by mothers delivering preterm infants.
MedLine Citation:
PMID:  4009386     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A prospective study was performed to find the possible difference in secretory IgA concentration in milk of mothers with term pregnancy labors and those delivering at earlier gestational ages. Since tocolytic drugs and/or glucocorticoid agents are usually given in cases of threatened premature labor, the pre-term group was divided into mothers with or without medication. Thirty two mothers were distributed in three groups: Group I, mothers with preterm labors without any medication; Group II, preterm labors with previous treatment with betamimetics and glucocorticoids; Group III, term labors (see Tab. I). In each of the three groups, three periods were studied: colostral (4 to 5 days postpartum), transitional (8 to 10 days), and mature (14 to 15 days). All mothers were healthy, with good nutritional state, without local inflammation and membranes had been ruptured 12 hours or less before labor. There was no significant difference in the proportion of primiparas and multiparas in both groups. The gestational age was evaluated by amenorrhea and neonatal examination. In all mothers milk was extracted with a vacuum pump to empty the mammary gland. The determinations were made using a specific antibody against the secretory component. The concentration of free secretory component in these milks was practically insignificant. No differences were found in the concentration of secretory IgA among the three groups (Tab. II, Fig. 1) in the periods that were studied, colostral, transitional or mature. The farther away from labor that milk extraction was made, in the periods considered in our study, there is a progressive decrease in the concentration of secretory IgA (Fig. 2).(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
M Martell; C Oehninger; C Scotti; L Delgado; M Martĭnez; I Korc
Related Documents :
12962926 - Is the intrapartum biophysical profile useful?
20506676 - Difficulties in controlling and preventing preterm labor in multiple gestations: a clin...
11573116 - A comparison of spontaneous labor with induced vaginal tablets prostaglandin e2 in gran...
18951216 - History of cesarean before 32 weeks' gestation and trial of labor: what is the risk of ...
24959596 - Vegf and enos expression in umbilical cord from pregnancy complicated by hypertensive d...
25193316 - Low birth weight at term and the presence of fine particulate matter and carbon monoxid...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of perinatal medicine     Volume:  13     ISSN:  0300-5577     ISO Abbreviation:  J Perinat Med     Publication Date:  1985  
Date Detail:
Created Date:  1985-08-12     Completed Date:  1985-08-12     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0361031     Medline TA:  J Perinat Med     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  61-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Betamethasone / pharmacology*,  therapeutic use
Ethanolamines / pharmacology*
Female
Fenoterol / pharmacology*,  therapeutic use
Gestational Age
Humans
Immunoglobulin A, Secretory / biosynthesis*
Infant, Newborn
Infant, Premature
Male
Milk, Human / drug effects*,  immunology
Obstetric Labor, Premature / drug therapy*
Pregnancy
Prospective Studies
Chemical
Reg. No./Substance:
0/Ethanolamines; 0/Immunoglobulin A, Secretory; 13392-18-2/Fenoterol; 378-44-9/Betamethasone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum and red blood cell folate levels in parturients, in the intervillous space of the placenta and...
Next Document:  Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alpre...